FDA Approves Omisirge Cell Therapy For Blood Cancers

RTTNews | 875 days ago

(RTTNews) - The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation.

Gamida Cell shares gained around 39 percent on Monday's regular trading. The gain continued in the after hours trading with a further growth of 4 percent.

Omisirge is a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils, i.e., a subset of white blood cells, in the body and reduce the risk of infection.

The product is intended for use in adults and pediatric patients 12 years and older with blood cancers planned for umbilical cord blood transplantation following a myeloablative conditioning regimen, treatment such as radiation or chemotherapy.

The Omisirge application received Priority Review, Breakthrough Therapy and Orphan designations.

Blood cancers are caused by uncontrolled growth of cells in the blood, disrupting the ability of blood cells to perform their normal functions.

Stem cell transplantation, which involves putting healthy stem cells into the body to help restore the normal production and function of blood cells, is a common treatment for blood cancers. One source of healthy stem cells is umbilical cord blood.

Omisirge, administered as a single intravenous dose, is composed of human allogeneic stem cells from umbilical cord blood that are processed and cultured with nicotinamide, a form of vitamin B3.

The FDA approval was based on the safety and effectiveness of Omisirge that was supported by a randomized, multicenter study comparing transplantation of Omisirge to transplantation of umbilical cord blood, in subjects between the ages of 12 and 65 years. All of 125 subjects in the study had confirmed blood cancers.

The agency noted that the efficacy of Omisirge was based on the amount of time needed for recovery of the subject's neutrophils, and the incidence of infections following transplantation.

In the trial, 87 percent of subjects who were randomized to receive Omisirge achieved neutrophil recovery with a median of 12 days following treatment with the product. This was compared to 83% of subjects who were randomized to receive umbilical cord blood transplantation and who achieved neutrophil recovery with a median of 22 days.

Further, the FDA warned that treatment with Omisirge has the potential to cause severe side effects, which must be considered in assessing the risks and benefits of using this product.

Similar to all approved umbilical cord products, the label carries a Boxed Warning for infusion reactions, graft versus host disease, engraftment syndrome, and graft failure.

Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said, "Today's approval is an important advance in cell therapy treatment in patients with blood cancers," said "Hastening the return of the body's white blood cells can reduce the possibility of serious or overwhelming infection associated with stem cell transplantation."

For More Such Health News, visit rttnews.com

Tags: GMDA

Gamida Cell Appoints Abigail Jenkins To Succeed Julian Adams As President And CEO

Gamida Cell Ltd. (GMDA) announced Monday that Abigail "Abbey" Jenkins, has joined as President & CEO. Jenkins has also been appointed to Gamida Cell's Board of Directors. Jenkins succeeds Julian Adams, who is retiring in accordance with planned succession and will continue to serve on the company's Board of Directors.

RTTNews | 1085 days ago

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market trading on Tuesday, adding to the losses in the previous session, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,800 level, with weakness in iron ore miners, financial and energy stocks partially offset by gains in gold miners.

RTTNews | 51 minutes ago

Asian Markets Mixed Amid Cautious Trades

Asian stock markets are trading mixed on Tuesday, following the broadly positive cues from Wall Street overnight, as traders remain optimistic about the outlook for interest rates following last week's weaker-than-expected US jobs data. They also remain cautious ahead of key U.S. inflation readings due later in the week that could influence the US Fed's rate trajectory.

RTTNews | 1h 25min ago

Sensex, Nifty Seen Higher At Open

Indian shares look set to open higher on Tuesday, even as volatility cannot be ruled out amid talk of more sanctions against Russia and ahead of key U.S. inflation readings due this week that could influence the Federal Reserve's rate trajectory.

RTTNews | 1h 54min ago

Higher Open Called For Thai Stock Market

The Thai stock market has moved higher in back-to-back sessions, adding almost 15 points or 1.2 percent along the way. The Stock Exchange of Thailand now sits just above the 1,265-point plateau and it may extend its winning streak again on Tuesday. The global forecast for the Asian markets is upbeat on optimism over the outlook for interest rates. The European and U.S. markets were modestly higher and the Asian bourses are expected to follow that lead. The SET finished slightly higher on Monday following gains from the food, consumer, finance, industrial, property and service sectors. For the day, the index was up 1.31 points or 0.10 percent to finish at 1,266.11 after trading between 1,264.79 and 1,276.15. Volume was 10.729 billion shares worth 54.546 billion baht. There were 278 gainers and 195 decliners, with 182 stocks finishing unchanged. Among the actives, Advanced Info skidded 1.02 percent, while Thailand Airport tumbled 1.95 percent, Banpu fell 0.40 percent, Bangkok Bank collected 0.66 percent, Bangkok Dusit Medical sank 0.95 percent, Bangkok Expressway soared 4.76 percent, B. Grimm retreated 1.54 percent, BTS Group rallied 4.24 percent, CP All Public jumped 1.58 percent, CP Axtra skyrocketed 14.14 percent, Charoen Pokphand Foods surged 4.44 percent, Energy Absolute stumbled 2.84 percent, Gulf plummeted 4.74 percent, Kasikornbank climbed 1.18 percent, Krung Thai Bank advanced 0.99 percent, Krung Thai Card dropped 0.85 percent, PTT Oil & Retail strengthened 1.39 percent, PTT improved 0.79 percent, PTT Global Chemical slumped 0.90 percent, SCG Packaging added 0.56 percent, Siam Commercial Bank shed 0.40 percent, Siam Concrete spiked 2.28 percent, TTB Bank skidded 1.05 percent and Asset World, True Corporation, PTT Exploration and Production and Thai Oil were unchanged.

RTTNews | 2h 24min ago

Japanese Market Significantly Higher

The Japanese stock market is trading significantly higher on Tuesday, extending the gains in the previous three sessions, despite the broadly positive cues from Wall Street overnight. The Nikkei 225 is moving above the 44,100 level to record all-time highs, after Prime Minister Shigeru Ishiba announced his resignation, with gains across most sectors led by exporters and technology stocks.

RTTNews | 2h 54min ago

Indonesia Bourse Expected To Halt Its Slide On Tuesday

The Indonesia stock market has moved lower in two straight sessions, sinking almost 120 points or 1.8 percent in that span. The Jakarta Composite Index now rests just above the 7,765-point plateau although it may stop the bleeding on Tuesday. The global forecast for the Asian markets is upbeat on optimism over the outlook for interest rates. The European and U.S. markets were modestly higher and the Asian bourses are expected to follow that lead. The JCI finished sharply lower on Monday following losses from the finance, food and telecom stocks, while the resource companies were mixed. For the day, the index tumbled 100.50 points or 1.28 percent to finish at 7,766.85 after trading between 7,766.85 and 7,934.99. Among the actives, Bank CIMB Niaga dipped 0.29 percent, while Bank Mandiri tanked 4.06 percent, Bank Danamon Indonesia skidded 1.18 percent, Bank Negara Indonesia stumbled 4.35 percent, Bank Central Asia surrendered 3.75 percent, Bank Rakyat Indonesia retreated 2.50 percent, Indosat Ooredoo Hutchison declined 2.04 percent, Indofood Sukses Makmur slumped 1.33 percent, United Tractors surged 4.34 percent, Astra International tumbled 1.36 percent, Energi Mega Persada dropped 2.50 percent, Astra Agro Lestari shed 0.68 percent, Aneka Tambang soared 6.49 percent, Vale Indonesia eased 0.26 percent, Timah rallied 5.83 percent, Bumi Resources sank 3.57 percent and Indocement and Semen Indonesia were unchanged.

RTTNews | 2h 54min ago

Hong Kong Shares Poised To Open To The Upside

The Hong Kong stock market has moved higher in consecutive trading days, climbing more than 675 points or 2.7 percent along the way. The Hang Seng Index now sits just above the 25,630-point plateau and it may see mild upside again on Tuesday. The global forecast for the Asian markets is upbeat on optimism over the outlook for interest rates. The European and U.S. markets were modestly higher and the Asian bourses are expected to follow that lead. The Hang Seng finished modestly higher on Monday following gains from the property stocks, technology companies and financial shares. For the day, the index gained 215.93 points or 0.85 percent to finish at 25,633.91 after trading between 25,387.81 and 25,664.01. Among the actives, Alibaba Group spiked 4.17 percent, while ANTA Sports climbed 0.85 percent, China Life Insurance sank 0.35 percent, China Mengniu Dairy and Nongfu Spring both shed 0.20 percent, China Resources Land improved 0.45 percent, CITIC surged 6.81 percent, CNOOC added 0.40 percent, CSPC Pharmaceutical accelerated 2.59 percent, Galaxy Entertainment advanced 0.58 percent, Hang Lung Properties gained 0.12 percent, Henderson Land increased 0.23 percent, Hong Kong & China Gas jumped 1.74 percent, Industrial and Commercial Bank of China collected 0.35 percent, JD.com strengthened 1.06 percent, Lenovo plunged 3.00 percent, Li Auto stumbled 1.02 percent, Li Ning rose 0.11 percent, Meituan slumped 0.97 percent, New World Development skyrocketed 17.40 percent, Techtronic Industries dipped 0.10 percent, Xiaomi Corporation rallied 2.05 percent, WuXi Biologics soared 5.52 percent and Haier Smart Home and Alibaba Health Info were unchanged.

RTTNews | 3h 9min ago

EURUSD	1.17683	GBPUSD	1.35673	AUDUSD	0.66015
USDJPY	147.244	USDCAD	1.38083	USDCHF	0.79267